Becoming Without: Making Transgenic Mosquitoes and Disease Control in Brazil
By Luísa Reis-Castro,
Duke University Press
| 11. 01. 2021
The First Bite
At the end of a day of fieldwork in Juazeiro, a city in Northeast Brazil, I sat in bed trying to write up my notes. A noisy fan in my small room was not alleviating the suffocating heat, so I moved to the porch to breath in some fresh air. Not long after I sat down, an itch on my left arm prompted a quick swat from my right hand. I turned my hand over to see a dead mosquito, with blood smeared on my skin. During my stay in Juazeiro, in the semiarid region of the Bahia state, mosquitoes, which in this region are broadly called muriçocas, were a constant presence. The itchiness caused by their bites is a nuisance, but they can also be dangerous: some mosquitoes convey disease pathogens. As I inspected the dead mosquito that afternoon my trained eye recognized its black-and-white stripes as a telltale signature of the Aedes aegypti, a species notorious for transmitting viruses such as dengue, chikungunya, Zika, and (urban) yellow fever.
It was the A. aegypti...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Rob Stein, NPR | 04.23.2026
The Food and Drug Administration approved the first gene therapy to restore hearing for people who were born deaf.
The decision, while only immediately affecting people born with a very rare form of genetic deafness, is being hailed as...
By Emily Mullin, Wired | 04.23.2026
A STARTUP OUT of Utah, Paterna Biosciences, says it has successfully grown functional human sperm in a lab and used the sperm to make visibly healthy-looking embryos. The technique could eventually help men with certain types of infertility have biological children...
By Julianna LeMieux, Genetic Engineering & Biotechnology News | 04.14.2026
Twenty years ago, Sven Bocklandt, PhD, sought to create a hypoallergenic cat. He had the genetic engineering chops to do it, but the embryology was beyond his capabilities. At a small animal genetic engineering conference, known as TARC (Transgenic Animal...